KFDA to permit postponement of bio equivalency test reports.

Published: 2007-03-23 06:58:00

Updated: 2007-03-23 06:58:00

The bio equivalency test reports for about 250 drugs could be submitted to the KFDA by the end of March considering many difficulties and problems to the drug industry. To lighten such heavy burdens to the industry, the KFDA may grant postponement of the test reports when an appropriate explanato...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK